Novel Aryl Hydrocarbon Receptor Agonist Compounds for Treating Psoriasis and Atopic Dermatitis
- PMID: 40529056
- PMCID: PMC12169485
- DOI: 10.1021/acsmedchemlett.5c00267
Novel Aryl Hydrocarbon Receptor Agonist Compounds for Treating Psoriasis and Atopic Dermatitis
Abstract
Provided herein are novel aryl hydrocarbon receptor (AHR) agonist compounds, pharmaceutical compositions, use of such compounds in treating immune-mediated diseases, in particular psoriasis and atopic dermatitis, and processes for preparing such compounds.
Published 2025 by American Chemical Society.
Similar articles
-
Novel AHR Agonists for Treating Psoriasis and Atopic Dermatitis.ACS Med Chem Lett. 2024 Jun 21;15(7):996-997. doi: 10.1021/acsmedchemlett.4c00262. eCollection 2024 Jul 11. ACS Med Chem Lett. 2024. PMID: 39015266 Free PMC article.
-
Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic Dermatitis.ACS Med Chem Lett. 2024 Nov 14;15(12):2095-2096. doi: 10.1021/acsmedchemlett.4c00537. eCollection 2024 Dec 12. ACS Med Chem Lett. 2024. PMID: 39691530
-
Characteristics and management of follicular events and contact dermatitis in patients using tapinarof cream for the treatment of atopic dermatitis or plaque psoriasis.J Dermatolog Treat. 2025 Dec;36(1):2517388. doi: 10.1080/09546634.2025.2517388. Epub 2025 Jul 2. J Dermatolog Treat. 2025. PMID: 40600584 Review.
-
Mapping ethical and social aspects of biomarker research and its application in atopic dermatitis and psoriasis: a systematic review of reason.J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1201-1213. doi: 10.1111/jdv.18128. Epub 2022 Apr 20. J Eur Acad Dermatol Venereol. 2022. PMID: 35366351
-
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources